Cramer Says Oneok Stock is a Buy
- Jim Cramer, host of 'Mad Money', endorses Oneok stock during a lightning round segment.
- He provides quick stock advice to callers, highlighting specific buy recommendations.
- Investors are encouraged to research further before making any investment decisions.
In the latest episode of "Mad Money," host Jim Cramer engaged with viewers during the lightning round, offering rapid-fire stock recommendations and insights. The segment, which aired on August 7, 2024, featured a mix of bullish and bearish sentiments on various companies, reflecting Cramer's candid approach to market analysis. Cramer expressed a positive outlook on Oneok, stating, "I think Oneok is terrific. I would indeed buy more," indicating confidence in the company's potential. Conversely, he advised caution regarding Dexcom, citing a significant earnings miss and a lack of clarity from the company. "I'd stay away from Dexcom," he warned, highlighting the importance of transparency in corporate communications. Additionally, Cramer discussed Dollar Tree, suggesting that its small store format is losing appeal as consumers gravitate towards larger retailers like Walmart and Costco. He emphasized that while Walmart is a buy, Dollar Tree may struggle to maintain its customer base. On a more optimistic note, he expressed enthusiasm for CRISPR Therapeutics, stating, "I happen to have a sweet spot for... I would be a buyer of CRISPR." Lastly, Cramer reaffirmed his support for KeyCorp, calling it a "terrific, terrific bank" and encouraging investors to hold onto their shares. As always, Cramer’s insights provide a blend of optimism and caution, guiding investors through the complexities of the stock market.